Raj Mehra - Net Worth and Insider Trading
Raj Mehra Net Worth
The estimated net worth of Raj Mehra is at least $998 dollars as of 2024-11-05. Raj Mehra is the See Remarks of Seelos Therapeutics Inc and owns about 1,446 shares of Seelos Therapeutics Inc (SEEL) stock worth over $998. Details can be seen in Raj Mehra's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raj Mehra has not made any transactions after 2023-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Raj Mehra
Raj Mehra Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raj Mehra owns 3 companies in total, including Seelos Therapeutics Inc (SEEL) , Larkspur Health Acquisition Corp (LSPR) , and ZyVersa Therapeutics Inc (ZVSA) .
Click here to see the complete history of Raj Mehra’s form 4 insider trades.
Insider Ownership Summary of Raj Mehra
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SEEL | Seelos Therapeutics Inc | 2023-12-01 | director & See Remarks |
| LSPR | Larkspur Health Acquisition Corp | 2021-12-20 | director |
| ZVSA | ZyVersa Therapeutics Inc | 2021-12-20 | director |
Raj Mehra Latest Holdings Summary
Raj Mehra currently owns a total of 1 stock. Raj Mehra owns 1,446 shares of Seelos Therapeutics Inc (SEEL) as of December 1, 2023, with a value of $998.
Latest Holdings of Raj Mehra
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SEEL | Seelos Therapeutics Inc | 2023-12-01 | 1,446 | 0.69 | 998 |
Holding Weightings of Raj Mehra
Raj Mehra Form 4 Trading Tracker
According to the SEC Form 4 filings, Raj Mehra has made a total of 3 transactions in Seelos Therapeutics Inc (SEEL) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Seelos Therapeutics Inc is the acquisition of 592 shares on December 1, 2023, which cost Raj Mehra around $99,999.
Insider Trading History of Raj Mehra
- 1
Raj Mehra Trading Performance
GuruFocus tracks the stock performance after each of Raj Mehra's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raj Mehra is -15.08%. GuruFocus also compares Raj Mehra's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raj Mehra within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Raj Mehra's insider trading performs compared to the benchmark.
Performance of Raj Mehra
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.64 | | | | | |
| Relative Return to S&P 500(%) | -10.43 | | | | | |
Raj Mehra Ownership Network
Ownership Network List of Raj Mehra
Ownership Network Relation of Raj Mehra
Raj Mehra Owned Company Details
What does Seelos Therapeutics Inc do?
Who are the key executives at Seelos Therapeutics Inc?
Raj Mehra is the director & See Remarks of Seelos Therapeutics Inc. Other key executives at Seelos Therapeutics Inc include Chief Financial Officer Michael Joseph Golembiewski , director & CEO & Secretary Richard W Pascoe , and SVP & Chief Business Officer Neil Morton .
Seelos Therapeutics Inc (SEEL) Insider Trades Summary
Over the past 18 months, Raj Mehra made 1 insider transaction in Seelos Therapeutics Inc (SEEL) with a net purchase of 75,757. Other recent insider transactions involving Seelos Therapeutics Inc (SEEL) include a net purchase of 83,000 shares made by Michael Joseph Golembiewski ,
In summary, during the past 3 months, insiders sold 0 shares of Seelos Therapeutics Inc (SEEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seelos Therapeutics Inc (SEEL) were sold and 1,240 shares were bought by its insiders, resulting in a net purchase of 1,240 shares.
Seelos Therapeutics Inc (SEEL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seelos Therapeutics Inc Insider Transactions
Raj Mehra Mailing Address
Above is the net worth, insider trading, and ownership report for Raj Mehra. You might contact Raj Mehra via mailing address: C/o Seelos Therapeutics, Inc., 300 Park Avenue, 12th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
